DE2729893A1 - Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens - Google Patents

Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens

Info

Publication number
DE2729893A1
DE2729893A1 DE19772729893 DE2729893A DE2729893A1 DE 2729893 A1 DE2729893 A1 DE 2729893A1 DE 19772729893 DE19772729893 DE 19772729893 DE 2729893 A DE2729893 A DE 2729893A DE 2729893 A1 DE2729893 A1 DE 2729893A1
Authority
DE
Germany
Prior art keywords
breast cancer
virus
protein
dna polymerase
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772729893
Other languages
German (de)
English (en)
Inventor
Sol Prof Spiegelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2729893A1 publication Critical patent/DE2729893A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19772729893 1977-05-23 1977-07-01 Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens Ceased DE2729893A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79981077A 1977-05-23 1977-05-23

Publications (1)

Publication Number Publication Date
DE2729893A1 true DE2729893A1 (de) 1978-11-30

Family

ID=25176811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772729893 Ceased DE2729893A1 (de) 1977-05-23 1977-07-01 Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens

Country Status (3)

Country Link
JP (3) JPS53145913A (ja)
CA (1) CA1108988A (ja)
DE (1) DE2729893A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040020A2 (en) * 1980-04-28 1981-11-18 Research Corporation Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
FR2489692A1 (fr) * 1980-09-05 1982-03-12 Univ Ramot Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu
EP0114342A2 (en) * 1982-12-23 1984-08-01 Director of The National Institute of Animal Health A method of producing reverse transcriptase
US4686194A (en) * 1982-04-21 1987-08-11 Bartos Patent Development & Holding Company, Limited Serioimmunological process for determining the in-vivo effectiveness of cytostatic agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755086A (en) * 1971-02-09 1973-08-28 Hoffmann La Roche Diagnostic method utilizing synthetic deoxyrilionucleotide oligomer template
US3859430A (en) * 1973-01-29 1975-01-07 Us Navy Radioactive iodine labeling of viruses, enzymes and flourescene isothyiocyanate
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755086A (en) * 1971-02-09 1973-08-28 Hoffmann La Roche Diagnostic method utilizing synthetic deoxyrilionucleotide oligomer template
US3859430A (en) * 1973-01-29 1975-01-07 Us Navy Radioactive iodine labeling of viruses, enzymes and flourescene isothyiocyanate
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
OHNO et al.: Proc. Natl. Acad. Sci., USA, Bd. 74, S. 2144-2148, 1977 *
OHNO et al.: Proc. Natl. Acad. Sci., USA, Bd. 74, S. 764-768, 1977 *
RITZI et al.: J. Exp. Med., Bd. 145, S. 999-1013, 1977 *
RITZI et al.: Proc. Natl. Acad. Sci., USA, Bd. 73, S. 4190-4194, 1976 *
RITZI et al.: Virology, Bd. 75, S. 188-197, 1976 *
SCHLOM et al.: Proc. Natl. Acad. Sci. U.S.A., Bd. 68, No. 7, S. 1613-1617, 1971 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040020A2 (en) * 1980-04-28 1981-11-18 Research Corporation Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
EP0040020A3 (en) * 1980-04-28 1982-01-13 Research Corporation Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
US4409200A (en) 1980-04-28 1983-10-11 Research Corporation Reverse transcriptase from human milk, method for its purification, and its use in the detection of breast cancer
FR2489692A1 (fr) * 1980-09-05 1982-03-12 Univ Ramot Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu
US4686194A (en) * 1982-04-21 1987-08-11 Bartos Patent Development & Holding Company, Limited Serioimmunological process for determining the in-vivo effectiveness of cytostatic agents
EP0114342A2 (en) * 1982-12-23 1984-08-01 Director of The National Institute of Animal Health A method of producing reverse transcriptase
EP0114342A3 (en) * 1982-12-23 1986-02-19 Nat Inst Animal Health A method of producing reverse transcriptase

Also Published As

Publication number Publication date
CA1108988A (en) 1981-09-15
JPS61247383A (ja) 1986-11-04
JPS6215826B2 (ja) 1987-04-09
JPS6327500A (ja) 1988-02-05
JPS53145913A (en) 1978-12-19

Similar Documents

Publication Publication Date Title
DE2915082C3 (de) Verfahren und Verwendung eines Reagenzsatzes zum Nachweis und zur Charakterisierung von Nukleinsäuren und ihren Sequenzen
Clark et al. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL
Jockers-Wretou et al. Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method
DE68928119T2 (de) Non-A, non-B-Hepatitisvirus-Antigenpeptid
DE2806146C2 (de) Tumor-spezifisches Glykoprotein und dessen Verwendung zur Krebsdiagnose beim Menschen
DE2648458C2 (de) Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens
Spaet et al. Studies on the mechanism whereby platelets are clumped by adenosine diphosphate
DE2548963A1 (de) Verfahren und mittel zur bestimmung der aktivitaet von creatinkinase-mb
DE60016275T2 (de) Helicobacter pylori antigene in blut
DE2128670B2 (de) Immunologische isoenzym-bestimmungsmethode
US4379839A (en) Method for detecting cancer
DE3788229T2 (de) Verfahren zur isolierung von ca 125-antigen.
CH657456A5 (de) Verfahren zum bestimmen der stoffwechselumwandlung von chemikalien und wirkstoffen.
DE3205301C2 (ja)
DE68918457T2 (de) Verfahren zur polymeraseaktivitätsbestimmung.
DE68909995T2 (de) Reagenz zur Bestimmung von Kreatinkinase und Messverfahren dafür.
Molnar et al. The Biosynthesis of Glycoproteins: V. Incorporation of Glucosamine-1-14C into Macromolecules by Ehrlich Ascites Carcinoma Cells
DE69231896T2 (de) Verfahren für die typ-spezifische detektion von herpes simplex virus
DE2729893A1 (de) Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens
US4046634A (en) Assay of isoenzymes by ion exchange chromatography
WO1992017608A1 (de) Verfahren zum nachweis der differenzierung und der invasivität von karzinomzellen
DE60217665T2 (de) Verfahren zur Bestimmung der Aktivität von Thymidinkinase-1 und dessen Verwendung
Goreau et al. Calcium uptake by a coral
DE69533439T2 (de) Thymidinkinase tk1, peptide, die korrespondierenden antikörper und ihre verwendung zur bestimmung der tumorproliferation
Rasmussen et al. Protein and enzyme changes in cold injury edema.

Legal Events

Date Code Title Description
OAM Search report available
OC Search report available
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C12Q 1/70

8131 Rejection